These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23003001)

  • 1. Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells--implications for stem cell therapies in regenerative medicine.
    Ratajczak J; Kucia M; Mierzejewska K; Marlicz W; Pietrzkowski Z; Wojakowski W; Greco NJ; Tendera M; Ratajczak MZ
    Stem Cells Dev; 2013 Feb; 22(3):422-30. PubMed ID: 23003001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function?
    Senegaglia AC; Barboza LA; Dallagiovanna B; Aita CA; Hansen P; Rebelatto CL; Aguiar AM; Miyague NI; Shigunov P; Barchiki F; Correa A; Olandoski M; Krieger MA; Brofman PR
    Exp Biol Med (Maywood); 2010 Jan; 235(1):119-29. PubMed ID: 20404026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo.
    Finney MR; Fanning LR; Joseph ME; Goldberg JL; Greco NJ; Bhakta S; Winter DG; Forster M; Scheid PE; Sabe M; Pompili VJ; Laughlin MJ
    Cytotherapy; 2010; 12(1):67-78. PubMed ID: 19878081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro.
    Nikolova T; Wu M; Brumbarov K; Alt R; Opitz H; Boheler KR; Cross M; Wobus AM
    Differentiation; 2007 Feb; 75(2):100-11. PubMed ID: 17316380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cord blood CD133 cells define an OV6-positive population that can be differentiated in vitro into engraftable bipotent hepatic progenitors.
    Crema A; Ledda M; De Carlo F; Fioretti D; Rinaldi M; Marchese R; Sanchez M; Giuliani M; Arena V; Durrbach A; Brunetti E; Haas C; Ponzetto A; Lisi A; Carloni G
    Stem Cells Dev; 2011 Nov; 20(11):2009-21. PubMed ID: 21291316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord blood-derived neurons are originated from CD133+/CD34 stem/progenitor cells in a cell-to-cell contact dependent manner.
    Zangiacomi V; Balon N; Maddens S; Lapierre V; Tiberghien P; Schlichter R; Versaux-Botteri C; Deschaseaux F
    Stem Cells Dev; 2008 Oct; 17(5):1005-16. PubMed ID: 18811243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling.
    Barcelos LS; Duplaa C; Kränkel N; Graiani G; Invernici G; Katare R; Siragusa M; Meloni M; Campesi I; Monica M; Simm A; Campagnolo P; Mangialardi G; Stevanato L; Alessandri G; Emanueli C; Madeddu P
    Circ Res; 2009 May; 104(9):1095-102. PubMed ID: 19342601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex-vivo expanded human blood-derived CD133+ cells promote repair of injured spinal cord.
    Kamei N; Kwon SM; Alev C; Nakanishi K; Yamada K; Masuda H; Ishikawa M; Kawamoto A; Ochi M; Asahara T
    J Neurol Sci; 2013 May; 328(1-2):41-50. PubMed ID: 23498368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD133(+) bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome.
    Cervelló I; Gil-Sanchis C; Santamaría X; Cabanillas S; Díaz A; Faus A; Pellicer A; Simón C
    Fertil Steril; 2015 Dec; 104(6):1552-60.e1-3. PubMed ID: 26384164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.
    Rufaihah AJ; Haider HK; Heng BC; Ye L; Tan RS; Toh WS; Tian XF; Sim EK; Cao T
    Regen Med; 2010 Mar; 5(2):231-44. PubMed ID: 20210583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal analysis reveals a common progenitor for endothelial, myeloid, and lymphoid precursors in umbilical cord blood.
    Ramos AL; Darabi R; Akbarloo N; Borges L; Catanese J; Dineen SP; Brekken RA; Perlingeiro RC
    Circ Res; 2010 Dec; 107(12):1460-9. PubMed ID: 20947832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term culture and identification of CD133⁺ hematopoietic progenitor cells from human umbilical cord blood].
    Wu XJ; Chen F; Lu YX; Yang H; Peng FL; Yuan L; Liu GB; Li XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):349-53. PubMed ID: 22445981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood.
    Baal N; Reisinger K; Jahr H; Bohle RM; Liang O; Münstedt K; Rao CV; Preissner KT; Zygmunt MT
    Thromb Haemost; 2004 Oct; 92(4):767-75. PubMed ID: 15467907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133(+) human umbilical cord blood stem cells enhance angiogenesis in experimental chronic hepatic fibrosis.
    Elkhafif N; El Baz H; Hammam O; Hassan S; Salah F; Mansour W; Mansy S; Yehia H; Zaki A; Magdy R
    APMIS; 2011 Jan; 119(1):66-75. PubMed ID: 21143528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.
    Gaipa G; Tilenni M; Straino S; Burba I; Zaccagnini G; Belotti D; Biagi E; Valentini M; Perseghin P; Parma M; Campli CD; Biondi A; Capogrossi MC; Pompilio G; Pesce M
    J Cell Mol Med; 2010 Jun; 14(6B):1619-34. PubMed ID: 19627397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells.
    Bonanno G; Mariotti A; Procoli A; Corallo M; Rutella S; Pessina G; Scambia G; Mancuso S; Pierelli L
    Transfusion; 2007 Feb; 47(2):280-9. PubMed ID: 17302775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro functional comparison of therapeutically relevant human vasculogenic progenitor cells used for cardiac cell therapy.
    Zhang Y; Wong S; Laflèche J; Crowe S; Mesana TG; Suuronen EJ; Ruel M
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):216-24, 224.e1-4. PubMed ID: 20167338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of differentiation and gene expression of CD133+ cells in human umbilical cord blood induced by SCF and bFGF].
    Zhang J; Zhu JS; Li QR; DU Y; Yang B; Li GX; Hu X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):146-50. PubMed ID: 20137136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.